Log In
Print
BCIQ
Print
Print this Print this
 

tasimelteon (VEC-162)

  Manage Alerts
Collapse Summary General Information
Company Vanda Pharmaceuticals Inc.
DescriptionMelatonin MT1 and MT2 receptor agonist
Molecular Target Melatonin MT1 receptor ; Melatonin MT2 receptor
Mechanism of ActionMelatonin MT1 receptor agonist
Latest Stage of DevelopmentPhase III
IndicationInsomnia
Partner

Bristol-Myers Squibb Co.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today